34095439|t|Inhibition of Tau aggregation with BSc3094 reduces Tau and decreases cognitive deficits in rTg4510 mice.
34095439|a|BACKGROUND: One of the major hallmarks of Alzheimer's disease (AD)is the aberrant modification and aggregation of the microtubule-associated protein Tau . The extent of Tau pathology correlates with cognitive decline, strongly implicating Tau in the pathogenesis of the disease. Because the inhibition of Tau aggregation may be a promising therapeutic target, we tested the efficacy of BSc3094, an inhibitor of Tau aggregation, in reducing Tau pathology and ameliorating the disease symptoms in transgenic mice. METHODS: Mice expressing human Tau with the P301L mutation (line rTg4510) were infused with BSc3094 into the lateral ventricle using Alzet osmotic pumps connected to a cannula that was placed on the skull of the mice, thus bypassing the blood-brain barrier (BBB) . The drug treatment lasted for 2 months, and the effect of BSc3094 on cognition and on reversing hallmarks of Tau pathology was assessed. RESULTS: BSc3094 significantly reduced the levels of Tau phosphorylation and sarkosyl-insoluble Tau. In addition, the drug improved cognition in different behavioral tasks and reduced anxiety-like behavior in the transgenic mice used in the study. CONCLUSIONS: Our in vivo investigations demonstrated that BSc3094 is capable of partially reducing the pathological hallmarks typically observed in Tau transgenic mice, highlighting BSc3094 as a promising compound for a future therapeutic approach for AD.
34095439	14	17	Tau	Gene	4137
34095439	35	42	BSc3094	Chemical	MESH:C524341
34095439	51	54	Tau	Gene	4137
34095439	69	87	cognitive deficits	Disease	MESH:D003072
34095439	91	98	rTg4510	CellLine	CVCL:G039
34095439	99	103	mice	Species	10090
34095439	147	166	Alzheimer's disease	Disease	MESH:D000544
34095439	168	170	AD	Disease	MESH:D000544
34095439	223	253	microtubule-associated protein	Gene	51115
34095439	254	257	Tau	Gene	4137
34095439	274	277	Tau	Gene	4137
34095439	304	321	cognitive decline	Disease	MESH:D003072
34095439	344	347	Tau	Gene	4137
34095439	410	413	Tau	Gene	4137
34095439	491	498	BSc3094	Chemical	MESH:C524341
34095439	516	519	Tau	Gene	4137
34095439	545	548	Tau	Gene	4137
34095439	611	615	mice	Species	10090
34095439	626	630	Mice	Species	10090
34095439	642	647	human	Species	9606
34095439	648	651	Tau	Gene	4137
34095439	661	666	P301L	ProteinMutation	tmVar:p|SUB|P|301|L;HGVS:p.P301L;VariantGroup:0;CorrespondingGene:4137;RS#:63751273;CorrespondingSpecies:9606;CA#:225444
34095439	682	689	rTg4510	CellLine	CVCL:G039
34095439	709	716	BSc3094	Chemical	MESH:C524341
34095439	829	833	mice	Species	10090
34095439	940	947	BSc3094	Chemical	MESH:C524341
34095439	991	994	Tau	Gene	4137
34095439	1028	1035	BSc3094	Chemical	MESH:C524341
34095439	1072	1075	Tau	Gene	4137
34095439	1096	1104	sarkosyl	Chemical	MESH:C025231
34095439	1115	1118	Tau	Gene	4137
34095439	1203	1210	anxiety	Disease	MESH:D001007
34095439	1243	1247	mice	Species	10090
34095439	1325	1332	BSc3094	Chemical	MESH:C524341
34095439	1415	1418	Tau	Gene	4137
34095439	1430	1434	mice	Species	10090
34095439	1449	1456	BSc3094	Chemical	MESH:C524341
34095439	1519	1521	AD	Disease	MESH:D000544
34095439	Negative_Correlation	MESH:C524341	MESH:D001007
34095439	Negative_Correlation	MESH:C524341	MESH:D000544
34095439	Association	MESH:D003072	4137
34095439	Association	MESH:D000544	4137
34095439	Association	MESH:C025231	4137
34095439	Negative_Correlation	MESH:C025231	MESH:C524341
34095439	Negative_Correlation	MESH:C524341	4137
34095439	Negative_Correlation	MESH:C524341	MESH:D003072
34095439	Association	MESH:D000544	51115

